CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-30 | Lebwohl David EVP, Chief Medical Officer | Sale | −700 | $156.70 | $110K | 2,291 |
| 2021-08-30 | Lebwohl David EVP, Chief Medical Officer | Sale | −250 | $157.60 | $39K | 2,041 |
| 2021-08-30 | Lebwohl David EVP, Chief Medical Officer | Sale | −1,100 | $159.19 | $175K | 941 |
| 2021-08-30 | Lebwohl David EVP, Chief Medical Officer | Sale | −150 | $160.10 | $24K | 791 |
| 2021-08-30 | Lebwohl David EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,400 | 195,200 | ||
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Option exercise | +5,200 | $19.27 | $100K | 5,200 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −704 | $153.22 | $108K | 4,496 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −1,100 | $154.29 | $170K | 3,396 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −1,700 | $155.29 | $264K | 1,696 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −300 | $156.10 | $47K | 1,396 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −496 | $157.33 | $78K | 900 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −300 | $158.42 | $48K | 600 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −300 | $159.53 | $48K | 300 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Sale | −300 | $160.84 | $48K | 0 |
| 2021-08-30 | Goddard Glenn EVP, Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,200 | 64,800 | ||
| 2021-08-23 | LEONARD JOHN M President and CEO | Option exercise | +27,139 | $13.40 | $364K | 746,444 |
| 2021-08-23 | LEONARD JOHN M President and CEO | Sale | −18,874 | $151.54 | $2.9M | 727,570 |
| 2021-08-23 | LEONARD JOHN M President and CEO | Sale | −8,165 | $153.08 | $1.2M | 719,405 |
| 2021-08-23 | LEONARD JOHN M President and CEO | Sale | −100 | $153.52 | $15K | 719,305 |
| 2021-08-23 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −27,139 | 224,138 |
Page 18 of 40 · 783 trades